Alumni

Meet the alumni companies of the Switzerland Innovation Park Basel Area.

Filter by

Abzu

Abzu was born from the desire to challenge the fundamental assumptions of contemporary, black box AI. Abzu’s pioneering artificial intelligence, the QLattice, accelerates analysis and insights through transparent and explainable models and inspires data scientists to be more scientific.

AdVentura Works SA

AdVentura Works is building a solution for remote driving of forklifts to help logistics and industrial companies tackle employee shortages, using computer vision, advanced sensors, Edge AI and human-robot collaboration.

Alltimm

Alltimm consults in technical development, Chemistry-Manufacturing-Controls (CMC), and supply chain for pharmaceutical products of small and large molecules.

Alpha Anoremic

Modulation of RNA holds the promise for opening up entirely new concepts for pharmaceutical intervention. Providing the precision tools to modulate this wealth of new RNA targets is our mission. Our development programs focus on severe neuromuscular diseases.

Amzell

Amzell acquires early-stage drug or combination product (drug-device) candidates and repurposed drugs and develops them through proof of concept to registration for sale to commercial healthcare companies.

AOT

It is the first company in the world to have developed a surgical robotic platform, named CARLO, to cut bone with a “cold” photoablation laser, leaving bone structures intact and vital, and thus pioneering the new field of “Laser-Osteotomy”.

Asterivir

Asterivir is a spin-out from the EPFL lab of Prof. Francesco Stellacci, licensing patents on broad-spectrum antivirals invented well before the emergence of SARS-CoV-2. Molecules employ a novel mechanism of action that renders circulating virions uninfective, showing superiority over oseltamivir (Tamiflu) in head-to-head comparisons in mice. Besides H1N1, the technology has also proven to be effective in-vivo against RSV, HSV-2 and most recently SARS-CoV-2.

Aurteen

Develops software that uses machine learning to provide low-cost non-invasive screening solutions to detect blinding disorders and brings accessible high-quality-diagnostic care to the general population.

Avelo

Avelo’s mission is to save lives by bringing fast and actionable infectious disease diagnosis to primary care. Our solution is a non-invasive sample-to-answer breath test that reliably detects multiple lower respiratory tract infections causing pneumonia within minutes.

Axom Solutions AG

Axom Solutions is using the latest deep learning pharmaceutical manufacturing images adding the flexibility and agility required by the production environment. The first counting product is used by companies to reduce the risk of mislabeled products. The plan is to develop automated inspection for injectable drugs – now often done manually.

B4SIS

Customers scan properties by themselves. As a result, the solution provides accurate plans and BIM models that have all necessary information embedded as a digital twin. This is addressing the lack of knowledge when it comes to renovation cost. The calculated reference costs are based on years of experience and market practice, making it a realistic calculation.

Bambooster

Bambooster enables organizations to embrace and scale innovation. They help teams create, prototype, and test new solutions. Whether you are willing to design value-added services for your customers or your upcoming launch, aiming at partnering with startups and other actors in your ecosystem…, or scaling innovative practices in your organization.

Bluenaut Matching Services AG

Bluenaut Matching Services AG operates online platforms that bring together searchers and providers of specialized services in a targeted manner.

Breathe

Breathe is our all-in-one solution for parents that supports and guides them through management of pediatric asthma. We are measuring quality of care delivered by parents to their children and real-world asthma data collected as part of daily disease management to analyze parental impact on the child’s asthma. Using this data we determine points of improvement and then deliver targeted enablement, exercises and feedback to parents that helps them better understand their child’s asthma and become better at asthma management.

Catalyze

Catalyze helps researchers and companies secure financing for ambitious R&D projects, from early-stage pre-clinical research up to clinical-stage development.

CIMEIO Therapeutics

CIMEIO develops game changing immunotherapies for leukemic tumors, non-malignant blood disorders, auto-immune diseases and tolerance for organ transplantation. This is achieved by “resetting the immune system” by eliminating diseased and healthy hematopietic stem cells (HSCs) utilizing CART-cells or monoclonal antibodies (mAb) and reconstituing the hematopietic system with allele engineered, “shielded” donor HCSs. HSCs are shielded against CART-cell or mAb attack by introducing a point mutation to a specific cell receptor.

Deep Breath Intelligence (DBI)

We aim to uncover the full potential of molecular gas analysis to improve patients lives and advance precision medicine by making it available for general health care. In essence, we analyze metabolites high tech real-time mass spectrometry, interprets the data with the help of machine learning tools in order to achieve clinical relevance. The entire services will be offered in a world first platform that will connect all industry players from patients, doctors, Pharma, CROs and hospitals.

DNA Global Analytics

DNA Global Analytics is a startup specialized in AI and Blockchain applied to the retail industry. DNA GA create tailor-made solutions to help retailers create new revenue streams using data-driven solutions (smart advertising screens, people counting system, etc.). The start-up already has clients abroad and its goal is to finalize a new prototype related to decentralized autonomous organizations.

Ersys Sàrl

ERSYS is a start-up focused on the design of the workstations of the future, offering an approach and products to preserve the health of employees and improve their productivity.

Exopharm

Their focus is on supplying reputable pharmaceutical goods, both branded and generic, with related medical accessories and services to all potential customers, specially, regional distributors in a competitive way.

Hypno VR SAS

HypnoVR is the leading designer and provider of certified digital therapies for the reduction of pain, stress and anxiety. Our solutions offer a safe and effective, non-drug treatment alternative that is easy to access for anyone. With 16 clinical researches and more than 250 Health care institutions that trust us, HypnoVR is accelerating the adoption of VR in pain management and healthcare.

InnoSpina

InnoSpina is a young NEI (New Innovative Company) specialized in the development of minimally invasive spinal implants and techniques. Our vision is to make back pain treatments safe, fast and cost-effective, bringing value to patients, surgeons and the healthcare system.

Intellective Bio

Intellective Bio is a biopharmaceutical CDMO accelerating research, product development, registration, and commercialization.

KETO Swiss

KetoSwiss is a University of Basel spinoff- brings an efficient and long-neglected fuel for the brain (ketone bodies) back into the modern world, to combat neurological diseases, such as migraine.

KetteRx GmbH

KetteRx GmbH is a Basel based company active in the field of creating, planning and operating biotech companies. The founders, two former Roche Pharma Partnering alumni and experienced dealmakers, Alexander Breidenbach, a drug development expert and Michael Motz, a chemist by training, have teamed up to scout for innovative scientific ideas and assets addressing unmet medical needs. We collaborate with the inventors to drive development of these projects with a pharma industry point of view. We lead the company creation tasks with the aim to become an investible entity for venture capital investors. Together, we will take care of securing funding and subsequent execution by leading the company operations up to a potential exit. KetteRx operates in close collaboration with large investors and acts as Entrepreneurs-in-Residence for BB Pureos Bioventures.

Nanome

Nanome, the first extended reality (XR) software company to launch an immersive real-time collaboration platform for scientific discovery, is changing the way we understand and interact with science at the molecular level. The software environment allows users to visualize, modify, and simulate proteins, chemical compounds, and nucleic acids to accelerate scientific decision making. The platform facilitates effective communication of data and integrates with existing computational chemistry workflows—features that have led to the adoption of the San Diego–based company’s enterprise solution by several pharmaceutical and biotech companies worldwide.

Pattern Biosciences AG

We are a non-profit lab for patients, caregivers, and innovators to co-create solutions that address everyday health challenges. We bring people, training, knowledge, and equipment together to help others to improve their lives step by step.

Plantik Biosciences

Algae Natural Food provides protein and/or omega 3 rich high quality micro-algae for food and feed applications – the production process for organic micro algae production is developed based on a sustainable and circular approach for a successful eco-conception.

Polyneuron Pharmaceuticals

Polyneuron is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases of the nervous system where a pathological role of anti-carbohydrate autoantibodies is well established. Polyneuron’s platform focus in on rare but devastating autoimmune diseases of the nervous system with an unmet medical need. The company’s Antibody-Catch™ technology platform enables the chemical design of injectable glycopolymers that are able to selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact. Polyneuron was founded as a University of Basel, Department of Pharmaceutical Sciences, spin-off in 2014.

Predemtec

Predemtec is active in research, development and manufacturing of innovative diagnostic tests for the diagnosis of risk factors of dementias.

Q-linked

Q-Linked consults, supports and accompanies enterprises during an envisaged ISO certification and provides high quality assistance during staffing bottleneck.

QCPT Services GmbH

Provides services in life science and information technology industry. The four letters QCPT stand for our service portfolio: Quality & Compliance services, Consulting services, Project Management and Training. Our Quality & Compliance services focus on Computerized System Validation, GxP assessments, Data Integrity, eCompliance Quality Assurance, GMP Quality Control Frameworks and internal audits related to these topics.

Sintetica

Founded in 1921 and headquartered in Mendrisio, Switzerland, our goal is to continuously strive to improve therapies, enhancing how they are formulated and used, for the benefit of clinicians and patients. We do so in close cooperation with clinical experts, who shape our understanding of their unmet needs and our efforts to address them. With this trust and insight, we push the limits of science and technology to make therapies safer, easier to use, and better for patients. In 2020 we reliably supplied millions of doses of improved therapies across a range of therapeutic classes, including anesthesia and analgesia, while expanding to address unmet needs.

Skyhawk therapeutics

At Skyhawk Therapeutics we use proprietary structural, kinetic, and computational models to invent small molecules that correct splicing in RNA, targeting some of the world’s most intractable diseases.

Soladis GmbH

Soladis is a service provider company specialized in data analytics. For over 20 years, we support our partners in their data related projects thanks to a team of 100+ highly skilled consultants with Statistical, Data Science and Medical expertise, both in North America and EU. We address a variety of customers, from SMEs to big multinational companies and have a particular focus on “Life Science” (i.e. Pharma, Medical Device, Biotech, Cosmetics etc.). We have developed several expertises in Statistics/Bioinformatics, Bioinformatics, Clinical Studies and Data Science/A.I. and have also our own training center.

Sotio

SOTIO has been building a diverse biotechnology portfolio through own R&D, partnering and investments since 2010. It’s focusing on immuno-oncology and developing innovative methods of the treatment of cancer. SOTIO is conducting multiple Phase I to III clinical trials and projects in preclinical stage. The company has facilities in Europe, the US, China and Russia.

SunRegen

SunRegen Healthcare AG is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases. We focus on innovative treatments for patients suffering from neurological, neuromuscular and ophthalmic diseases. Our first product candidates in development target primary optical atrophy. We are further evaluating them for use in serious neurological / neuromuscular diseases such as ALS, Huntington’s, Alzheimer’s and Parkinson’s disease.

Swiss Vault Systems AG

Swiss Vault Systems has the best-in-class solution for storage of large data. Our unique hardware design and software setup ensures rapid analysis, with secure long-term storage at very low energy consumption.

TOSA Swisstech

TOSA Swisstech will develop a manufacturing process and provide a solution to substitute metal bipolar plates, an essential element of these cells (it represent >30% of the price and >70% of the weight) by composite bipolar plates. Developed product is ultralight, durable, non corrosive, compact and efficient.

uniQure

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. The recent approvals of our gene therapy for hemophilia B – an historic achievement based on more than a decade of research and clinical development – represent a major milestone in the field of genomic medicine and ushers in a new treatment approach for patients living with hemophilia. We are now leveraging our modular and validated technology platform to advance a pipeline of proprietary gene therapies for the treatment of patients with Huntington’s disease, refractory temporal lobe epilepsy, ALS, Fabry disease, and other severe diseases.

Versameb

Versameb AG is a privately held company focusing on discovering and developing innovative RNA-based drugs for modulation of protein expression and cellular targeting. Versameb’s proprietary technology platform optimizes the application of functional mRNA in different disease contexts. The company is based in Basel, Switzerland and is fully operating since 2018.

Volv Global SA

Volv help to diagnose patients with difficult to diagnose or rare diseases with our inTrigue product.

Worg pharmaceuticals

Worg Pharmaceuticals (Hangzhou) Co., Ltd. is a clinical stage biopharmaceutical company developing new treatments for allergy and autoimmune diseases with high unmet medical needs and considerable commercial potential.Headquartered in Hangzhou at the heart of one of China’s biotech hubs, Worg was founded in 2018 and led by an executive team from China, the United States and Europe who have extensive experience in life science executive, pharmaceutical development, clinical trials, regulatory affairs and commercialization. Worg plans to build the pipeline of allergy and other therapeutical indications through internal development and external partnering with flexible options.

Zühlke

Zühlke is a global innovation service provider. We envisage ideas and create new business models for our clients by developing services and products based on new technologies from the initial vision through development to deployment, production and operation.
No residents found.